Intravitreal aflibercept for choroidal neovascularization secondary to angioid streaks in a non-responder to intravitreal ranibizumab

PURPOSE: To report the 12-month outcomes of a patient switching from intravitreal ranibizumab to aflibercept for choroidal neovascularization (CNV) associated with angioid streaks (AS). RESULTS: A 42-year-old Caucasian female with CNV associated with AS underwent intensive treatment with ranibizumab...

Full description

Saved in:
Bibliographic Details
Published in:Int Med Case Rep J
Main Authors: Makri, Olga E, Tsapardoni, Foteini N, Plotas, Panagiotis, Pallikari, Athina, Georgakopoulos, Constantine D
Format: Artigo
Language:Inglês
Published: Dove Medical Press 2018
Subjects:
Case Report
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6149836/
https://ncbi.nlm.nih.gov/pubmed/30271222
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IMCRJ.S166473
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items